Jaguar Health, Inc. (JAGX) › Cash & EquivalentsJaguar Health, Inc. (JAGX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $185.4K2014: $845.2K2015: $7.70M2016: $951.0K2017: $520.7K2018: $2.57M2019: $3.50M2020: $8.09M2021: $17.05M2022: $5.47M2023: $6.47M2024: $8.00M2025: $968.0K$968.0K2013Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$968.0K-87.9%2024$8.00M+23.7%2023$6.47M+18.3%2022$5.47M-67.9%2021$17.05M+110.8%2020$8.09M+131.5%2019$3.50M+36.1%2018$2.57M+393.2%2017$520.7K-45.2%2016$951.0K-87.6%2015$7.70M+810.7%2014$845.2K+356.0%2013$185.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share